Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Tumor Board Review - Evidence-Based Case Reviews and Questions (Paperback, 3rd Revised edition)
Loot Price: R2,053
Discovery Miles 20 530
|
|
Tumor Board Review - Evidence-Based Case Reviews and Questions (Paperback, 3rd Revised edition)
Expected to ship within 12 - 17 working days
|
Now in its 3rd edition, Tumor Board Review: Evidence-Based Case
Reviews and Questions is the most comprehensive clinical case
review book in the field. With hands-on input from current fellows
and oncologists, this new edition has been enhanced and reformatted
for greater efficiency and practicality. The review covers all
disease-site areas in oncology and features a wide variety of
board-style questions pivotal in helping fellows and oncologists
prepare for both the ABIM medical oncology board exam and
maintenance of certification (MOC) assessments. Evidence-based
discussions of difficult patient cases offer an in-depth and
accurate depiction of what is discussed at tumor boards and foster
critical thinking essential for clinical practice. Patient cases
also highlight impactful treatment decisions that include newly
approved immunotherapies and targeted therapies. Each chapter
contains digestible essentials for each case, including a summary
of diagnosis, molecular and genomic testing, treatment options,
toxicity considerations, follow-up, and survivorship. Each chapter
ends with high-yield multiple-choice questions including answers
and detailed rationales ensuring readers are well-equipped with the
knowledge they need to make well-informed, individualized treatment
decisions. Tumor Board Review: Evidence-Based Case Review and
Questions is an essential case-based reference for anyone working
in oncology. Key Features: Describes more than 120 patient cases,
including locally advanced and metastatic cases for each major
disease site Contains 300 board-style questions and answers related
to case reviews Includes new advances in diagnosis and therapy,
with a greater emphasis on immunotherapies, cancer genomics, and
precision-based targeted therapies Provides essentials for toxicity
considerations, follow-up, and survivorship considerations
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.